Keyword Analysis & Research: clinicaltrials.gov pfizer

clinicaltrials.gov:443

https://classic.clinicaltrials.gov:443/ct2/show/NCT04816643

WEBMar 25, 2021 · ClinicalTrials.gov Identifier: NCT04816643. Recruitment Status : Completed. First Posted : March 25, 2021. Last Update Posted : December 19, 2023. …

DA: 9 PA: 30 MOZ Rank: 3

clinicaltrials.gov:443

https://classic.clinicaltrials.gov:443/ct2/show/NCT05020236

WEBAug 25, 2021 · ClinicalTrials.gov Identifier: NCT05020236. Recruitment Status : Recruiting. First Posted : August 25, 2021. Last Update Posted : March 12, 2024. See … Allocation: Randomized Intervention Model: Factorial Assignment Estimated Enrollment : 762 participants Study Type : Interventional (Clinical Trial)

Allocation: Randomized

Intervention Model: Factorial Assignment

Estimated Enrollment : 762 participants

Study Type : Interventional (Clinical Trial)

DA: 31 PA: 34 MOZ Rank: 50

clinicaltrials.gov:443

https://classic.clinicaltrials.gov:443/ct2/show/NCT04848584

WEBApr 19, 2021 · ClinicalTrials.gov Identifier: NCT04848584. Recruitment Status : Recruiting. First Posted : April 19, 2021. Last Update Posted : February 6, 2024. See Contacts and …

DA: 96 PA: 60 MOZ Rank: 96

clinicaltrials.gov:443

https://classic.clinicaltrials.gov:443/ct2/show/NCT04754594

WEBClinicalTrials.gov Identifier: NCT04754594. Recruitment Status : Completed. First Posted : February 15, 2021. Last Update Posted : July 13, 2023. View this study on the … Actual Enrollment : 683 participants Intervention Model: Parallel Assignment Allocation: Randomized Study Type : Interventional (Clinical Trial)

Actual Enrollment : 683 participants

Intervention Model: Parallel Assignment

Allocation: Randomized

Study Type : Interventional (Clinical Trial)

DA: 44 PA: 31 MOZ Rank: 36

nejm.org:443

https://www.nejm.org:443/doi/full/10.1056/NEJMoa2200674

WEBMar 23, 2022 · In an ongoing pivotal clinical trial (C4591001) involving healthy children and adults who were 12 years of age or older, two doses of the BNT162b2 vaccine (30 μg) were safe, immunogenic, and at...

DA: 34 PA: 30 MOZ Rank: 9

pfizer.com:443

https://www.pfizer.com:443/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine

WEBNov 18, 2020 · A breakdown of the diversity of clinical trial participants can be found here from approximately 150 clinical trials sites in United States, Germany, Turkey, South …

DA: 52 PA: 93 MOZ Rank: 32

nejm.org:443

https://www.nejm.org:443/doi/full/10.1056/NEJMoa2034577

WEBDec 10, 2020 · (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728 .) Quick Take. Safety and Efficacy of the BNT162b2 Covid-19 Vaccine. 3m 0s.

DA: 46 PA: 74 MOZ Rank: 31

pfizer.com:443

https://www.pfizer.com:443/news/press-release/press-release-detail/pfizer-announces-additional-phase-23-study-results

WEBFor more information on the EPIC Phase 2/3 clinical trials for PAXLOVID, visit clinicaltrials.gov. About Pfizer: Breakthroughs That Change Patients’ Lives. At Pfizer, …

DA: 4 PA: 48 MOZ Rank: 88

nejm.org:443

https://www.nejm.org:443/doi/full/10.1056/NEJMoa2107456

WEBPublished May 27, 2021. N Engl J Med 2021;385: 239 - 250. DOI: 10.1056/NEJMoa2107456. VOL. 385 NO. 3. Abstract. Background. Until very recently, vaccines against severe acute respiratory syndrome...

DA: 68 PA: 94 MOZ Rank: 5

pfizer.com:443

https://www.pfizer.com:443/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate

WEBNov 5, 2021 · 2024. Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR …

DA: 40 PA: 29 MOZ Rank: 83